Clinical Trials Browser

INDUSTRY × Glioblastoma × Dasatinib × Clear all

NCT00948389 2012-08-31

Study of CCNU (Lomustine) Plus Dasatinib in Recurrent Glioblastoma (GBM)

Phase 1/2 Terminated

28 enrolled 16 charts

Glioblastoma